一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-11-27,10% Owner,DUGGAN ROBERT W ,买入,77585普通股, $1.68
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-11-23,10% Owner,DUGGAN ROBERT W ,买入,80175普通股, $1.89
$Achaogen, Inc.(AKAO)$ CT ORDER - Confidential treatment order Filed: 2018-11-27 AccNo: 9999999997-18-009121 Size: 88 KB 网页链接
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-11-20,10% Owner,DUGGAN ROBERT W ,买入,231495普通股, $1.93
$Achaogen, Inc.(AKAO)$ 内部交易: 2018-11-19,10% Owner,DUGGAN ROBERT W ,买入,4648普通股, $1.62
$Achaogen, Inc.(AKAO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-08 AccNo: 0001564590-18-028650 Size: 10 MB 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001564590-18-028301 Size: 183 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Achaogen, Inc.(AKAO)$ 美东时间 2018-11-08 盘前 披露财报,预期EPS -0.96 网页链接
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-11-02 AccNo: 0001564590-18-026523 Size: 33 KBItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 9.01: Financial Statements and Exhibits http:/...
$Achaogen, Inc.(AKAO)$ 8-K - Current report Filed: 2018-10-17 AccNo: 0001564590-18-024386 Size: 64 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接